Atlas Ventures – Venture Capital – VC

Types/sectors – Biotechnology, Software, Mobile
Stages of investing – Venture Capital that does Seed, Early Stage Venture, Later Stage Venture, Private Equity, and Debt Financing Investments
History – founded in 1980. In 2009, Atlas significantly consolidated its investment operations and has been a proponent of the lean start-up approach.
In 2014, Atlas’ technology team launched two initiatives Maiden Lane, an investment platform built to invest in AngelList Syndicates, and Boston Syndicates, an investment program that sponsors investments made by New England based angels.
Fund value – $280 million
Founders and partners – Frank Castellucci, Jeff Fagnan, Jon Karlen, Chris Lynch, Ryan Moore
Notable investments, and value – UNUM Therapeutics $65M Series B, PillPack $50M Series C, Nimbus Therapeutics $43M Series B
Headquarters – Cambridge, MA, United States